Skip to main content
NAR Cancer logoLink to NAR Cancer
. 2021 Sep 22;3(3):zcab041. doi: 10.1093/narcan/zcab041

Correction to ‘Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer’

Adrian P Wiegmans 1,2,✉,2, Ambber Ward 3,4,2, Ekaterina Ivanova 5, Pascal H G Duijf 6,7,8, Mark N Adams 9, Idris Mohd Najib 10, Romy Van Oosterhout 11, Martin C Sadowski 12, Greg Kelly 13,14, Scott W Morrical 15, Ken O’Byrne 16, Jason S Lee 17,18,19,3, Derek J Richard 20,3
PMCID: PMC8457359  PMID: 34570837

The Authors wish to make the following corrections to their article (1).

Affiliations 2 and 3 have been corrected to:

2School of Medicine, University of Queensland, Herston, QLD, 4006, Australia

3Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia

Jason S. Lee wishes to add another affiliation:

7School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia

The Publisher omitted the following joint authorship statement:

The authors wish it to be known that, in their opinion, the last two authors should be regarded as Joint Last Authors

The published article has been updated to reflect these corrections.

Contributor Information

Adrian P Wiegmans, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia; School of Medicine, University of Queensland, Herston, QLD, 4006, Australia.

Ambber Ward, School of Medicine, University of Queensland, Herston, QLD, 4006, Australia; Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Ekaterina Ivanova, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

Pascal H G Duijf, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia; Centre for Data Science, Queensland University of Technology (QUT), Brisbane, QLD, Australia; University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia.

Mark N Adams, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

Idris Mohd Najib, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

Romy Van Oosterhout, Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Martin C Sadowski, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

Greg Kelly, School of Medicine, University of Queensland, Herston, QLD, 4006, Australia; Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.

Scott W Morrical, Department of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.

Ken O’Byrne, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

Jason S Lee, School of Medicine, University of Queensland, Herston, QLD, 4006, Australia; Epigenetics and Diseases Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia; School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.

Derek J Richard, Queensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Translational Research Institute, Woolloongabba QLD 4121, Australia.

REFERENCES

  • 1.Wiegmans A.P., Ward A., Ivanova E., Duijf P.H.G., Adams M.N., Najib I.M., Oosterhout RV., Sadowski M.C., Kelly G., Morrical S.W.et al.. Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer. NAR Cancer. 2021; 3:zcab022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from NAR Cancer are provided here courtesy of Oxford University Press

RESOURCES